INTELLIA THERAPEUTICS INC (NTLA) Institutional Ownership and Insiders Activity
INTELLIA THERAPEUTICS INC (NTLA) is widely held by institutional investors, with 319 firms reporting positions valued at approximately $2.44B based on SEC Form 13F filings for the quarter ended June 30, 2026.
ARK Invest is the largest disclosed holder, reporting approximately $285.54M in NTLA holdings in its latest filing.
Recent insider activity includes 5 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.
Institutional Holders
319
Total Reported Value
$2.44B
Largest Holder
ARK Invest
Largest Position
$285.54M
Insider Transactions (90d)
5
Latest Filing Quarter
Q2 2026
New Institutional Positions
55
Funds Exiting Positions
37
Top Institutional Owners
View allInvestorReported Balance
- ARK Invest$285.54M
- Blackrock, Inc.$260.72M
- State Street Corp$156.26M
- Vanguard Portfolio Management Llc$124.06M
- D. E. Shaw & Co., Inc.$109.02M
NTLA News
All news- Regeneron Pharmaceuticals Top Holdings: A Deep Dive into NTLA
Aug 10, 2026 · valut.ai
Related NTLA Institutional Insights:
- NTLA 13F Institutional Holders
- NTLA Top Institutional Shareholders
- NTLA Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- NTLA Insider Trading & SEC Form 4 Activity
- NTLA Articles
- Top Institutional Investor Stock Rankings